Results 41 to 50 of about 12,750 (218)

MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease [PDF]

, 2015
MicroRNA (miRNA) has the potential for cross-regulation and functional integration of discrete biological processes during complex physiological events.
Akbar, Moeed, Campbell, Abigail L., Gilchrist, Derek, Kerr, Shauna C., Kurowska-Stolarska, Mariola, Liew, Foo Y., McInnes, Iain B., Millar, Neal L., Murrell, George A.C., Reilly, James H.   +9 more
core   +1 more source

Somatostatin receptor in human hepatocellular carcinomas: Biological, patient and tumor characteristics [PDF]

, 2008
Background/Aim: The evidence on the efficacy of somatostatin analogues in the treatment of hepatocellular carcinoma (HCC) in humans is conflicting. A variety of human tumors demonstrate somatostatin receptors.
Alers JC, Allgaier HP, Baek MJ, Blaker M, C. Verhoef, C.H.J. van Eijck, Dimitrouloupoulos D, Edamoto Y, El-Serag H, H. van Dekken, Hofland L, Hsu HC, Hsu HC, J.H.W. de Wilt, J.N.M. IJzermans, Korner M, Kouroumalis E, Kumar U, L.J. Hofland, Lamberts SW, Matsuda Y, P.E. Zondervan, Qin LX, R. van Marion, R.A. de Man, Raderer M, Reubi JC, Reubi JC, Reynaert H, Samonakis DN, Schally AV, Schwartz JD, Van Dekken H, Van Dekken J, Verhoef C, Weckbecker G, Yuen MF, Zhang CY   +37 more
core   +7 more sources

Soluble suppression of tumorigenicity 2 and echocardiography in sepsis [PDF]

, 2016
Soluble suppression of tumorigenicity 2 (sST2) has emerged as a biomarker of cardiac stretch or remodeling, and has demonstrated a role in acutely decompensated heart failure. However, its role in sepsis-induced cardiac dysfunction is still unknown.
Hanah Kim, Hyun Suk Yang, Laura Magrini, Mina Hur, null null, Rossella Marino, Salvatore Di Somma   +6 more
core   +1 more source

Primary sources and immunological prerequisites for sST2 secretion in humans [PDF]

Cardiovascular Research, 2010
Serum levels of the soluble growth stimulation gene-2 (sST2) are elevated in heart and pulmonary diseases. However, the relationship of the sST2/interleukin (IL)-33 axis and its triggers as well as its organ distribution is still not known. This study was thus designed to investigate the cellular origin and regulation of sST2 and IL-33 in vitro and in ...
Michael, Mildner, Angela, Storka, Michael, Lichtenauer, Veronika, Mlitz, Minoo, Ghannadan, Konrad, Hoetzenecker, Stefanie, Nickl, Balazs, Dome, Erwin, Tschachler, Hendrik Jan, Ankersmit   +9 more
openaire   +2 more sources

Comparison between soluble ST2 and high-sensitivity troponin I in predicting short-term mortality for patients presenting to the Emergency Department with chest pain [PDF]

, 2016
Background: High-sensitivity cardiac troponin I (hs-cTnI) and the soluble isoform of suppression of tumorigenicity 2 (sST2) are useful prognostic biomarkers in acute coronary syndrome (ACS).
Francesca Orsini, Gerardo Salerno, Laura Magrini, Mina Hur, null null, Patrizia Cardelli, Rossella Marino, Salvatore Di Somma, Veronica Russo   +8 more
core   +1 more source

Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices [PDF]

, 2004
Somatostatin-14 (SRIF) reduces hippocampal epileptiform activity but the contribution of its specific receptors (sst1-5) is poorly understood. We have focused on sst1 and sst2 role in mediating SRIF modulation of epilepsy using hippocampal slices of wild
Bagnoli, Paola, Cammalleri, Maurizio, Cervia, Davide, Dal Monte, Massimo, Hoyer, Daniel, Langenegger, Daniel, Liu, Yanqiang   +6 more
core   +1 more source

Prognostic Value of β1 Adrenergic Receptor Autoantibody and Soluble Suppression of Tumorigenicity-2 in Patients With Acutely Decompensated Heart Failure

Frontiers in Cardiovascular Medicine, 2022
BackgroundBoth β1 adrenergic receptor autoantibody (β1-AA) and soluble suppression of tumorigenicity-2 (sST2) take a role in the pathological remodeling of heart failure.
Yanxiang Sun, Li Feng, Bing Hu, Jianting Dong, Liting Zhang, Xuansheng Huang, Yong Yuan   +6 more
doaj   +1 more source

Predictive value of soluble ST2 in adolescent and adult patients with complex congenital heart disease. [PDF]

PLoS ONE, 2018
BACKGROUND:Soluble suppression of tumorogenicity 2 (sST2) has been shown to be of prognostic value in patients with chronic and acute left heart failure.
Mohammed Laqqan, Christiane Schwaighofer, Stefan Graeber, Tanja Raedle-Hurst   +3 more
doaj   +1 more source

Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome

Frontiers in Cardiovascular Medicine, 2021
Background: Recent studies have suggested that soluble suppression of tumorigenicity-2 (sST2), an inflammation-related protein receptor, is associated with atherosclerotic diseases.
Guqing Luo, Yuxuan Qian, Xincheng Sheng, Jiateng Sun, Zhinan Wu, Fei Liao, Qi Feng, Yan Yin, Song Ding, Jun Pu   +9 more
doaj   +1 more source

Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction. [PDF]

, 2020
Background Coronary artery aneurysms and myocarditis are well-recognized complications of Kawasaki disease (KD) but no systematic evaluation of the consequences of myocarditis has been performed in the subset presenting with low ejection fraction (EF ...
Burns, Jane C, He, Feng, Hoshino, Shinsuke, Jain, Sonia, Shimizu, Chisato, Tremoulet, Adriana H   +5 more
core